Becton Dickinson & Co. is recalling approximately 12,383 units of the BD BACTEC MGIT 960 PZA Kit, which is used in laboratories to test the susceptibility of tuberculosis bacteria to the drug pyrazinamide (PZA). The kits may intermittently produce false results indicating the bacteria is resistant to the drug when it is actually sensitive. This defect could lead to patients receiving incorrect or unnecessary treatment for tuberculosis. These kits were distributed worldwide, including across the United States, and the firm has initiated a voluntary recall to address the diagnostic error.
If a test incorrectly shows that tuberculosis is resistant to pyrazinamide, a doctor might prescribe a more toxic or less effective alternative medication. This can lead to unnecessary side effects for the patient or a delay in effective treatment for a serious infection.
Manufacturer consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.